Putative growth characteristics of micrometastatic breast cancer
- PMID: 19090969
- PMCID: PMC2656890
- DOI: 10.1186/bcr2197
Putative growth characteristics of micrometastatic breast cancer
Abstract
The fate of cells that disseminate from a primary breast tumour remains poorly understood. Studies of the kinetics of recurrence in breast cancer patients are raising important questions about the biology of the metastatic process. Where do tumour cells reside once they leave the primary tumour, and what factors influence their dormancy and recurrent growth? Clinical data analyses are leading to hypotheses about the biology of metastasis, dormancy and recurrence. A combined clinical and experimental approach to testing these hypotheses will help to clarify this important issue in breast cancer biology and patient care.
Comment on
-
Recurrence dynamics does not depend on the recurrence site.Breast Cancer Res. 2008;10(5):R83. doi: 10.1186/bcr2152. Epub 2008 Oct 9. Breast Cancer Res. 2008. PMID: 18844974 Free PMC article.
Similar articles
-
Tumour dormancy: findings and hypotheses from clinical research on breast cancer.Semin Cancer Biol. 2001 Aug;11(4):297-306. doi: 10.1006/scbi.2001.0385. Semin Cancer Biol. 2001. PMID: 11513565 Review.
-
Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.Breast Dis. 2006-2007;26:87-98. doi: 10.3233/bd-2007-26108. Breast Dis. 2006. PMID: 17473368 Review.
-
Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer.Endocrinology. 2022 Jun 1;163(6):bqac055. doi: 10.1210/endocr/bqac055. Endocrinology. 2022. PMID: 35560214 Review.
-
Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery.Ann Surg Oncol. 2008 Oct;15(10):2954-64. doi: 10.1245/s10434-008-0037-5. Epub 2008 Jul 12. Ann Surg Oncol. 2008. PMID: 18622646
-
Proposal for a new model of breast cancer metastatic development.Ann Oncol. 1997 Nov;8(11):1075-80. doi: 10.1023/a:1008263116022. Ann Oncol. 1997. PMID: 9426326 Review.
Cited by
-
Breast cancer as a systemic disease: a view of metastasis.J Intern Med. 2013 Aug;274(2):113-26. doi: 10.1111/joim.12084. J Intern Med. 2013. PMID: 23844915 Free PMC article. Review.
-
Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases.Breast Cancer Res Treat. 2014 Aug;146(3):627-36. doi: 10.1007/s10549-014-3057-9. Epub 2014 Jul 20. Breast Cancer Res Treat. 2014. PMID: 25038878 Free PMC article.
-
What can be learnt about disease progression in breast cancer dormancy from relapse data?PLoS One. 2013 May 6;8(5):e62320. doi: 10.1371/journal.pone.0062320. Print 2013. PLoS One. 2013. PMID: 23671591 Free PMC article.
-
Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways.Mol Cells. 2012 Feb;33(2):127-33. doi: 10.1007/s10059-012-2182-8. Epub 2012 Jan 2. Mol Cells. 2012. PMID: 22228181 Free PMC article.
-
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.Breast Cancer Res. 2014 Jul 25;16(4):407. doi: 10.1186/s13058-014-0407-9. Breast Cancer Res. 2014. PMID: 25060555 Free PMC article.
References
-
- Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996;14:2738–2746. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical